Back to results
US 2003/0148957 A1Published application
Corticotropin releasing factor 2 receptor agonists
AssigneeThe Procter & Gamble Company
InventorsRobert Joseph Isfort, Wieslaw Adam Mazur
Life of this patent
Estimating the term…
Abstract
Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
Claims22
A non-native peptide comprising the sequence
- -ZGPPISIDLPX12X13LLRKX18IEIEKQEKEKQQAX32X33NAX36X37LX39X40X41
- wherein:
- X12 is selected from F, Y, L, I, and T;
- X13 is selected from Q, W, and Y;
- X18 is selected from V and M;
- X32 is selected from T and A;
- X33 is selected from N and T;
- X36 is selected from R and L;
- X37 is selected from L and I;
- X39 is selected from D and A;
- X40 is selected from T and R;
- X41 is selected from I and V;
- and variants thereof.
10 more elements
Dependencies are inferred from the claim text.